Istesso
London
About Istesso
Istesso is a drug discovery and development company working in the field of immunometabolism. Our pipeline of pre-clinical and clinical assets act by reprogramming metabolism to treat autoimmune and inflammatory conditions such as rheumatoid arthritis and multiple sclerosis. Istesso was founded in 2017 as the holding company for Modern Biosciences Ltd.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $13.1M
- Last round: Series Unknown (Feb 2019)
- Website: istesso.co.uk
- Phone: +44 (0) 207 444 0066
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/istesso-148124 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.